Search research articles
Contact Us
Filters
Showing results (191-200 of 422) with videos related to
Page
of 43
Sort By:
Scientific Reports
|
June 20, 2024
Differential extracellular vesicle concentration and their biomarker expression of integrin α<sub>v</sub>/β<sub>5</sub>, EpCAM, and glypican-1 in pancreatic cancer models
Reed Jacobson, Sangdeuk Ha, Sakurako Tani, et al.
Cancer Research
|
September 19, 2015
Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens
Shikhar Uttam, Hoa V Pham, Justin LaFace, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 13, 1998
Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors
M H Wang, E Brand-Schieber, B A Zand, et al.
Oncotarget
|
August 4, 2016
Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets
Jinyun Chen, Xifeng Wu, Yujing Huang, et al.
World Journal of Gastroenterology
|
July 29, 2006
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking
Rhonda M Brand, David D Jones, Henry T Lynch, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 6, 2019
Three-Dimensional Nanoscale Nuclear Architecture Mapping of Rectal Biopsies Detects Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
Shikhar Uttam, Jana G Hashash, Justin LaFace, et al.
Cancer Investigation
|
July 31, 2007
Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma
Benedito A Carneiro, Randall E Brand, Elita Fine, et al.
Journal of Biomedical Optics
|
June 28, 2012
Investigation of nuclear nano-morphology marker as a biomarker for cancer risk assessment using a mouse model
Rajan K Bista, Shikhar Uttam, Douglas J Hartman, et al.
Scientific Reports
|
January 3, 2023
rxCOV is a quantitative metric for assessing immunoassay analyte fidelity
Rhonda M Brand, Danielle Pitlor, E Jeffrey Metter, et al.
Molecular Oncology
|
May 18, 2016
Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer
Suhasini Joshi, Eric Cruz, Satyanarayana Rachagani, et al.
Page
of 43
Search research articles
Search
Showing results (191-200 of 422) with videos related to
Sort By:
Page
of 43
Scientific Reports
|
June 20, 2024
Differential extracellular vesicle concentration and their biomarker expression of integrin α<sub>v</sub>/β<sub>5</sub>, EpCAM, and glypican-1 in pancreatic cancer models
Reed Jacobson, Sangdeuk Ha, Sakurako Tani, et al.
Cancer Research
|
September 19, 2015
Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens
Shikhar Uttam, Hoa V Pham, Justin LaFace, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 13, 1998
Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors
M H Wang, E Brand-Schieber, B A Zand, et al.
Oncotarget
|
August 4, 2016
Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets
Jinyun Chen, Xifeng Wu, Yujing Huang, et al.
World Journal of Gastroenterology
|
July 29, 2006
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking
Rhonda M Brand, David D Jones, Henry T Lynch, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 6, 2019
Three-Dimensional Nanoscale Nuclear Architecture Mapping of Rectal Biopsies Detects Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
Shikhar Uttam, Jana G Hashash, Justin LaFace, et al.
Cancer Investigation
|
July 31, 2007
Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma
Benedito A Carneiro, Randall E Brand, Elita Fine, et al.
Journal of Biomedical Optics
|
June 28, 2012
Investigation of nuclear nano-morphology marker as a biomarker for cancer risk assessment using a mouse model
Rajan K Bista, Shikhar Uttam, Douglas J Hartman, et al.
Scientific Reports
|
January 3, 2023
rxCOV is a quantitative metric for assessing immunoassay analyte fidelity
Rhonda M Brand, Danielle Pitlor, E Jeffrey Metter, et al.
Molecular Oncology
|
May 18, 2016
Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer
Suhasini Joshi, Eric Cruz, Satyanarayana Rachagani, et al.
Page
of 43